Zydus Lifesciences Signs Major Acquisition Deal with Amplitude Surgical

Deal News | Apr 25, 2025 | PR Newswire Cision Zydus Lifesciences Limited

Zydus Lifesciences Limited has signed an acquisition agreement to secure a 75.4% stake in Amplitude Surgical SA, a leader in surgical technology for orthopedics. This stake purchase involves PAI Partners, Olivier Jallabert, and Amplitude's management and aims to increase Zydus's holding to over 85% when combined with previous agreements with minority shareholders. The transaction value is set at €6.25 per share. Zydus awaits approval from French authorities under foreign investment regulations, alongside standard conditions such as significant investment from Olivier Jallabert back into Amplitude. The acquisition's completion is expected by Q3 2025, following which Zydus intends to launch a mandatory public offer and possibly enforce a squeeze-out process if conditions are met. Amplitude Surgical, founded in 1997, is renowned for its high-end orthopedic surgical products, with a strong presence in France and operations in over 30 countries. In 2024, it reported revenues of around €106 million.

Sectors

  • Healthcare
  • Private Equity & Investment

Geography

  • India – Zydus Lifesciences is headquartered in Ahmedabad, India, making it a key geography in the transaction.
  • France – Amplitude Surgical is based in Valence, France, and the acquisition involves compliance with French foreign investment regulations.

Industry

  • Healthcare – The transaction involves Zydus Lifesciences, a company operating in the pharmaceutical and medical sectors, acquiring Amplitude Surgical, which specializes in orthopedic surgical technologies.
  • Private Equity & Investment – PAI Partners, a private equity firm, is involved as a selling shareholder in the acquisition of Amplitude Surgical by Zydus Lifesciences.

Financials

  • 6.25 – Per share acquisition price for Amplitude stocks by Zydus Lifesciences.
  • 106 million – Amplitude Surgical's revenue as of June 2024.

Participants

NameRoleTypeDescription
Zydus Lifesciences LimitedBuyerCompanyAn innovative global company in the life sciences sector, focused on providing health solutions.
Amplitude Surgical SATargetCompanyA leading French firm in orthopedic surgical technologies, known for its innovations in hip and knee procedures.
PAI PartnersVendorCompanyA private equity firm that is selling its stake in Amplitude Surgical to Zydus Lifesciences.
Olivier JallabertVendorPersonAn individual stakeholder in Amplitude who is partially reinvesting in the company post-acquisition.
Autorité des marchés financiers (AMF)Regulatory AuthorityGovernmentThe French financial markets authority overseeing the public offer aspect of the acquisition.